高剂量早期活动对糖尿病患者结局的影响:TEAM试验二次分析
本研究为TEAM试验的二次分析,纳入全部741例ICU患者,其中159例(21.4%)患有糖尿病,旨在评估糖尿病是否改变早期活动剂量与临床结局的关系。主要结局为180天存活且出院天数。结果显示,糖尿病患者接受高剂量早期活动后180天死亡风险增加(校正OR 3.47,95%CI 1.67-7.61),交互作用P=0.001,而180天存活且出院天数无显著差异。
要点
- 糖尿病患者占ICU患者的21.4%,其180天存活且出院天数更少、死亡率更高。
- 高剂量早期活动未显著改善糖尿病患者180天存活且出院天数。
- 糖尿病患者接受高剂量早期活动后180天死亡风险增加(校正OR 3.47)。
核心结论
- 在TEAM试验的二次分析中,糖尿病患者接受高剂量早期活动策略未显著减少180天存活且出院天数,但增加了180天死亡率。
研究设计与样本
- TEAM试验的二次分析,纳入全部741例ICU患者,其中159例(21.4%)患有糖尿病。
- 采用逻辑回归和中位数回归模型探讨高剂量早期活动对结局的影响是否受糖尿病状态修饰。
主要发现
- 糖尿病患者180天存活且出院天数少于非糖尿病患者(124 [0-153] vs. 147 [82-164];P = 0.013)。
- 糖尿病患者180天死亡率高于非糖尿病患者(30% vs. 18%;P = 0.044)。
- 接受高剂量早期活动的糖尿病患者180天存活且出院天数为73.0(0.0-144.5),非糖尿病患者为146.5(95.8-163.0),交互作用P = 0.108。
- 糖尿病患者接受高剂量早期活动后180天死亡风险增加(校正OR 3.47;95%CI 1.67-7.61;交互作用P = 0.001)。
临床怎么用
- 对ICU糖尿病患者实施高剂量早期活动策略时需谨慎评估死亡风险。
局限性
- 本研究为TEAM试验的二次分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Patients with diabetes represent almost 20% of all ICU admissions and might respond differently to high-dose early active mobilization. Objectives: To assess whether diabetes modified the relationship between the dose of early mobilization on clinical outcomes in the TEAM trial. Methods: All TEAM trial patients were included. The primary outcome was days alive and out of the hospital at Day 180. Secondary outcomes included 180-day mortality and long-term functional outcomes at Day 180. Logistic and median regression models were used to explore the effect of high-dose early mobilization on outcomes by diabetes status. Measurements and Main Results: All 741 patients from the original trial were included. Of these, 159 patients (21.4%) had diabetes. Patients with diabetes had fewer days alive and out of the hospital at Day 180 (124 [0-153] vs. 147 [82-164]; P = 0.013) and higher 180-day mortality (30% vs. 18%; P = 0.044). In patients receiving high-dose early mobilization, the number of days alive and out of the hospital at Day 180 was 73.0 (0.0-144.5) in patients with diabetes and 146.5 (95.8-163.0) in patients without diabetes (P value for interaction = 0.108). However, in patients with diabetes, high-dose early mobilization increased the odds of mortality at 180 days (adjusted odds ratio, 3.47; 95% confidence interval, 1.67-7.61; P value for interaction = 0.001). Conclusions: In this secondary analysis of the TEAM trial, in patients with diabetes, a high-dose early mobilization strategy did not significantly decrease the number of days alive and out of the hospital at Day 180, but it increased 180-day mortality.
引用
- Serpa Neto A, Bailey M, Seller D, et al. Impact of High-Dose Early Mobilization on Outcomes for Patients with Diabetes: A Secondary Analysis of the TEAM Trial. Am J Respir Crit Care Med. 2024. PMID: 38763167. doi:10.1164/rccm.202312-2289OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。